Home > Quotes > AQXP

Aquinox Pharmaceuticals, Inc. Stock Quote & Summary Data

AQXP 
$9.75
*  
0.03
0.31%
Get AQXP Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading AQXP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Best Bid/Ask "Best Bid" is the highest price currently being offered for a block of stock.
"Best Ask" is the lowest price currently being asked for a block of stock.
N/A / N/A
1 Year Target 21.5
Today's High /Low "Today's High" The highest sales price the stock has achieved during the regular trading hours, the intra-day high.
"Today's Low" The lowest sales price the stock has fallen to during the regular trading hours, the intra-day low.
 / 
Share Volume "Share Volume" is the number of shares of the stock traded on the listing exchange during current trading hours. It does not include after hours volume.
50 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 17,078
Previous Close "Previous Close" is the previous trading day's last reported trade price during official trading hours. $ 9.78
52 Week High/Low "52 Week High" is the highest sales price the stock has achieved during the regular trading hours during the most recent 52 week period.
"52 Week Low" is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period.
$ 14.35 / $ 5.50
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 104,277,303
Annualized dividend N/A
Ex Dividend Date N/A
Dividend Payment Date N/A
Current Yield Indicated yield represents annual dividends divided by current stock price. 0 %
Beta "Beta" is a volatility measurement of a stock mutual fund or ETF versus a comparable benchmark like the S&P 500 stock index. A stock fund or ETF with a higher beta than the S&P 500 will rise or fall to a greater degree. In contrast, a stock fund or ETF with a low beta will rise or fall less. -0.67
NASDAQ Official Open Price NASDAQ Official Opening Price: This process identifies the NASDAQ-specific opening prices for NASDAQ-listed issues. $ 10.07
Date of Open Price "Date of Open Price" This field refers to the date the NASDAQ Official Open Price was disseminated for a given stock. It is possible that the date will not be from the current trading day; this indicates that the stock didn't trade on NASDAQ during the current trading day. The NASDAQ Official Open Price is updated only when the stock is traded on NASDAQ. Feb. 27, 2015
NASDAQ Official Close Price "NASDAQ Official Closing Price (NOCP)" is a process for identifying the NASDAQ market-specific closing price for NASDAQ-listed issues. $ 9.75
Date of Close Price This field refers to the date the NOCP was disseminated for a given stock. It is possible that the date will not be from the prior day; this indicates that the stock didn't trade on NASDAQ on the prior day. The NOCP is updated only when the stock is traded on NASDAQ. Feb. 27, 2015
Community Sentiment

Intraday Chart

Company Description (as filed with the SEC)

We are a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation and cancer. Our primary focus is anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. Our lead product candidate, AQX-1125, is a SHIP1 activator and has demonstrated broad anti-inflammatory activity. AQX-1125 has successfully completed three clinical trials dosed as a once daily oral product with over 100 subjects having received AQX-1125 to date. We are currently investigating AQX-1125 in two Phase 2 clinical trials, one for Chronic Obstructive Pulmonary Disease, or COPD, and one for Bladder Pain Syndrome/Interstitial Cystitis, or BPS/IC. COPD and BPS/IC are debilitating chronic inflammatory diseases affecting millions of people worldwide. Inflammation can be reduced by activation of SHIP1, which is a natural modulator of the PI3K pathway.  ... More ...  

Risk Grade

Where does AQXP fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?